ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716408 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716408; 2) Community: the network communities that were significantly associated with the response to NSC 716408; 3) Molecule: the relationships between components within communities and NSC 716408; 4) MDR: the compounds that were significantly associated with the NSC 716408.

NSC Compound Enrichment Correlation
NSC 645892 Naphtho[2,3-f]quinoxaline-7,12-dione, 3-hydroxy-2-methyl- 0.0352383000003058 -0.045442339
NSC 648114 ANTINEOPLASTIC-D648114 0.0352383000003058 0.35058162
NSC 648365 Insulin-Methotrexate conjugate 0.0352383000003058 0.21321139
NSC 649677 Null 0.0352383000003058 0.2464811
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.0352383000003058 0.36828157
NSC 665484 Null 0.0352383000003058 0.44584654
NSC 673453 Null 0.0352383000003058 0.57010595
NSC 676916 1-[m-methyl anilino malonyl]-3-methyl-4-[4'-.beta.-sulphato ethyl sulphonyl phenyl azo]-5-pyrazolone 0.0352383000003058 0.32925485
NSC 682827 Propanimidoyl chloride, 2-methyl- N-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]oxy]- 0.0352383000003058 0.31521793
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.0352383000003058 0.35194908
Total:178  Current:142    [First] [Prev] [Next] [Last]